Clinically Actionable Hypertrophic Cardiomyopathy Genes in South Asian Indian Patients
The clinically actionable gene variants in SAI HCM differed significantly from other global HCM cohorts, specifically <i>MYBPC3</i>, <i>MYH7</i>, and <i>MYH6</i>.
Authors
- Kurukkanparampil Sreedharan Mohanan
- Thiagarajan Sairam (ORCID: https://orcid.org/0000-0001-5571-0462)
- Vinay J. Rao (ORCID: https://orcid.org/0000-0002-2188-7670)
- Jayaprakash Shenthar (ORCID: https://orcid.org/0000-0003-4509-7515)
- Hisham Ahamed (ORCID: https://orcid.org/0000-0002-1740-8948)
- Perundurai S. Dhandapany (ORCID: https://orcid.org/0000-0001-7831-9570)
- Andiappan Rathinavel
Institutions
- Amrita Institute of Medical Sciences and Research Centre (IN)
- Madurai Medical College (IN)
- Government Medical College (IN)
- Government Rajaji Hospital (IN)
- Sri Jayadeva Institute of Cardiovascular Sciences and Research (IN)
- University of Trans-Disciplinary Health Sciences and Technology (IN)
- Institute for Stem Cell Biology and Regenerative Medicine (IN)
- Government College Kodanchery (IN)
- Amrita Vishwa Vidyapeetham (IN)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1161/jaha.125.042036
- Citations
- 4
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.55